8-K: NEXGEL Announces Record Preliminary Q2 2024 Revenue and Issues Strong Revenue Guidance

NEXGEL reports record preliminary revenue of $1.4 million for Q2 2024, with significant year-over-year and sequential growth, and provides optimistic revenue guidance for the remainder of the year.

Summary

• NEXGEL announced preliminary, unaudited revenue of $1.4 million for the second quarter of 2024.
• This represents a 20% increase year-over-year and a 10% increase sequentially.
• The company has issued revenue guidance of $2.2 million for the third quarter of 2024, which is an 83% increase year-over-year.
• Revenue guidance for the fourth quarter of 2024 is $2.6 million, a 140% increase year-over-year.
• The growth is attributed to new customer relationships with large global corporations in contract manufacturing and strong consumer demand for their brands, particularly Silly George's new Pop-On Lash product line.
• The company expects to move to positive cash flow from operations in the second half of the year.

Sentiment

Score: 9

Explanation: The document conveys a very positive sentiment due to record revenue, strong growth projections, and positive management commentary. The company's outlook for the second half of the year is optimistic, and the expectation of positive cash flow further enhances the positive sentiment.

Positives

• The company achieved record revenue in the second quarter of 2024.
• There was significant year-over-year and sequential revenue growth in Q2 2024.
• The company has provided strong revenue guidance for the third and fourth quarters of 2024.
• New customer relationships with large global corporations are driving growth in contract manufacturing.
• Strong consumer demand for brands like Silly George is contributing to revenue growth.
• The company expects to achieve positive cash flow from operations in the second half of the year.

Negatives

• Q2 revenue was impacted by lower-than-normal revenues at CG Converting and Packaging due to the move into a newly expanded facility.
• The preliminary results are subject to customary quarter-end adjustments and may change.

Risks

• The preliminary financial results are subject to change pending finalization and review by the company's independent registered public accounting firm.
• Actual results may differ materially from the current expectations expressed in the release due to various factors.
• The company's forward-looking statements are subject to risks and uncertainties that could impact actual results.

Future Outlook

NEXGEL anticipates significant revenue growth in the second half of 2024, driven by contract manufacturing and consumer product sales, and expects to move to positive cash flow from operations. The company's projections for Q3 and Q4 do not yet include any revenue from their relationship with AbbVie.

Management Comments

• Adam Levy, CEO of NEXGEL, stated that they are pleased to deliver record revenue for the second quarter of 2024 despite lower-than-normal revenues at CG Converting and Packaging.
• Adam Levy also mentioned that the outlook for the second half of the year has exceeded expectations for both contract manufacturing and consumer products.
• The CEO noted that the growth in contract manufacturing is primarily due to new customer relationships with large global corporations.
• He also highlighted the strong consumer demand for the new Pop-On Lash product line from Silly George.

Industry Context

This announcement indicates a positive growth trajectory for NEXGEL in the medical and over-the-counter product market, particularly in the hydrogel sector. The company's focus on both contract manufacturing and its own brands positions it well to capitalize on market opportunities. The growth in contract manufacturing suggests a strong demand for their manufacturing capabilities from larger corporations.

Comparison to Industry Standards

• While specific competitor data is not provided in the document, the 20% year-over-year revenue growth in Q2 and the projected 83% and 140% year-over-year growth in Q3 and Q4 respectively, suggest a strong performance compared to industry averages. Companies like 3M in the medical device space and Johnson & Johnson in consumer health could be considered benchmarks, but direct comparisons are difficult without specific market data.
• The company's focus on hydrogel technology is a niche market, and the growth suggests a strong demand for their products. The contract manufacturing growth indicates that larger companies are recognizing the value of their technology and manufacturing capabilities.
• The success of the Silly George brand and the new Pop-On Lash product line indicates a strong understanding of consumer trends and effective product development.

Stakeholder Impact

• Shareholders are likely to react positively to the record revenue and strong growth projections.
• Employees may be motivated by the company's positive performance and growth prospects.
• Customers will benefit from the company's continued innovation and product development.
• Suppliers may see increased demand for their products and services.
• Creditors may view the company as a lower risk due to its improved financial performance.

Next Steps

• The company will finalize its financial results for the second quarter ended June 30, 2024.
• The company will continue to focus on growing its contract manufacturing business and its own brands.
• The company will work towards achieving positive cash flow from operations in the second half of 2024.

Key Dates

Keywords

revenue, NEXGEL, hydrogels, contract manufacturing, consumer products, preliminary results, revenue guidance, Silly George, positive cash flow